Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy.
Gao F, Jing P, Liu J, Lu Y, Zhang P, Han W, Liu G, Ru N, Cui G, Sun C, Che Y, Zhang H, Hu Q, Wang HY, Wu Y, Guan C, Fu Q, Ma Z, Yu B.
Gao F, et al.
J Hepatocell Carcinoma. 2015 Jun 10;2:57-68. doi: 10.2147/JHC.S80756. eCollection 2015.
J Hepatocell Carcinoma. 2015.
PMID: 27508195
Free PMC article.